By expenditures
| Name | Title | Type |
|---|---|---|
| Claire Selib | Executive Director | Auditee |
| Kevin B. Stouffer, Cpa | Member Of The Firm | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 343826 | 2024 | 2025-02-26 | Smith Elliott Kearns & Company LLC | $1.15M |
| 304930 | 2023 | 2024-04-29 | Smith Elliott Kearns & Company LLC | $901,856 |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 304930 | 2023 | 2024-04-29 | 971466 | 2023-007 | - | - | L |
| 304930 | 2023 | 2024-04-29 | 971465 | 2023-006 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 971464 | 2023-005 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 971463 | 2023-004 | Material Weakness | - | AB |
| 304930 | 2023 | 2024-04-29 | 971462 | 2023-003 | Material Weakness | - | ABCHL |
| 304930 | 2023 | 2024-04-29 | 971461 | 2023-007 | - | - | L |
| 304930 | 2023 | 2024-04-29 | 971460 | 2023-006 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 971459 | 2023-005 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 971458 | 2023-004 | Material Weakness | - | AB |
| 304930 | 2023 | 2024-04-29 | 971457 | 2023-003 | Material Weakness | - | ABCHL |
| 304930 | 2023 | 2024-04-29 | 971456 | 2023-007 | - | - | L |
| 304930 | 2023 | 2024-04-29 | 971455 | 2023-006 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 971454 | 2023-005 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 971453 | 2023-004 | Material Weakness | - | AB |
| 304930 | 2023 | 2024-04-29 | 971452 | 2023-003 | Material Weakness | - | ABCHL |
| 304930 | 2023 | 2024-04-29 | 971451 | 2023-007 | - | - | L |
| 304930 | 2023 | 2024-04-29 | 971450 | 2023-006 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 971449 | 2023-005 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 971448 | 2023-004 | Material Weakness | - | AB |
| 304930 | 2023 | 2024-04-29 | 971447 | 2023-003 | Material Weakness | - | ABCHL |
| 304930 | 2023 | 2024-04-29 | 395024 | 2023-007 | - | - | L |
| 304930 | 2023 | 2024-04-29 | 395023 | 2023-006 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 395022 | 2023-005 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 395021 | 2023-004 | Material Weakness | - | AB |
| 304930 | 2023 | 2024-04-29 | 395020 | 2023-003 | Material Weakness | - | ABCHL |
| 304930 | 2023 | 2024-04-29 | 395019 | 2023-007 | - | - | L |
| 304930 | 2023 | 2024-04-29 | 395018 | 2023-006 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 395017 | 2023-005 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 395016 | 2023-004 | Material Weakness | - | AB |
| 304930 | 2023 | 2024-04-29 | 395015 | 2023-003 | Material Weakness | - | ABCHL |
| 304930 | 2023 | 2024-04-29 | 395014 | 2023-007 | - | - | L |
| 304930 | 2023 | 2024-04-29 | 395013 | 2023-006 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 395012 | 2023-005 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 395011 | 2023-004 | Material Weakness | - | AB |
| 304930 | 2023 | 2024-04-29 | 395010 | 2023-003 | Material Weakness | - | ABCHL |
| 304930 | 2023 | 2024-04-29 | 395009 | 2023-007 | - | - | L |
| 304930 | 2023 | 2024-04-29 | 395008 | 2023-006 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 395007 | 2023-005 | Significant Deficiency | - | L |
| 304930 | 2023 | 2024-04-29 | 395006 | 2023-004 | Material Weakness | - | AB |
| 304930 | 2023 | 2024-04-29 | 395005 | 2023-003 | Material Weakness | - | ABCHL |